Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
(Midi does not prescribe this or other unapproved peptides.) What the science says: Theres promising preclinical (aka animal or lab) data on MOTS-c, and early research suggests that MOTS-c may improve metabolism by activating the AMPK pathway and help reverse age-related insulin resistance
Cells also harbor multiple parallel, GPX4-independent antiferroptotic pathways, many of which rely on endogenous radical-trapping antioxidants (RTAs) that directly quench lipid radicals (Fig
References to clinical trials and published research throughout this description are provided for informational and research context only and do not constitute medical claims or endorsements of any therapeutic application of this product.
theobromae proliferation and spreading around the infection sites (Zhang et al
There is an added benefit, if these two products are taken together
Unlike native FOXO4, which contributes to the survival of senescent cells, FOXO4-DRI has been developed in experimental models to selectively interfere with senescence-associated signaling pathways
